Transglutaminases: new target molecules for inflammatory bowel disease?
Siegmund
B
B
Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik I, Hindenburgdamm 30, 12200 Berlin, Germany. britta.siegmund@charite.de
Zeitz
M
M
D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000201:enzymology; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000201:enzymology*; D011503:Transglutaminases / Q000502:physiology*
D005765:Gastrointestinal Agents; D011503:Transglutaminases